NovMetaPharma Co., Ltd. (XKON:229500)
South Korea · Delayed Price · Currency is KRW 4,890.00
+390.00 (8.67%)
At close: Sep 3, 2026
NovMetaPharma Revenue
In the year 2014, NovMetaPharma had annual revenue of 1.30B KRW with 21.36% growth.
Revenue
1.30B
Revenue Growth
+21.36%
P/S Ratio
48.47
Revenue / Employee
n/a
Employees
n/a
Market Cap
62.80B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2014 | 1.30B | 227.98M | 21.36% |
| Dec 31, 2013 | 1.07B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.